Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone ...

In today’s Health Alert, obstructive sleep apnea may soon be treated with a simple, once-a-day pill. This first-in-class oral ...

Sleep apnea doesn’t just disrupt your rest, it can lead to serious health issues like high blood pressure, heart disease, and ...

Dr. David Jin We're not just treating snoring-we're helping save lives and save marriages.” - Dr. David JinFORT LEE, NJ, UNITED STATE ...

Resmed CEO Mick Farrell addressed the latest potential threats to the CPAP therapy market during a recent webcast: The ...

Two Key Hires Add Significant Experience and Strengthen Vivos’ Ability to Scale Its Promising New Sleep Testing Center and ...

ASX heath sector fell 0.65% in past five days. Morgans' Scott Power notes the June quarterly reporting season has been 'mostly pretty good'.

More sleep apnea patients are turning to their dentist to get better rest, because some dentists are able to offer a ...

Apnimed's experimental drug reduced breathing interruptions by nearly 46.8% in clinical trials, offering a potential ...

Topline results were announced from a second phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in patients with OSA.

Incannex's IHL-42X showed significant efficacy in Phase 2 sleep apnea trial, with strong AHI reduction, improved sleep, and ...

Apnimed, a pharmaceutical company developing oral therapies for obstructive sleep apnea (OSA) and related conditions, announced positive topline results from its second pivotal Phase 3 trial of AD109 ...